Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Cross-species molecular stratification enables T cell receptor diagnosis of Parkinson's disease.

Created on 23 Oct 2026

Authors

Jiayu Chen, Xian Xia, Yuruo Zhang, Xiaoge Tong, Yue Liang, Xiangding Fan, Qinghao Meng, Yihong Wei, Gang Hu

Published in

Genome medicine. Volume 18. Issue 1. Sep 29, 2026. Epub Sep 29, 2026.

Abstract

Developing peripheral blood-based diagnostic models for idiopathic Parkinson's disease (iPD), particularly those leveraging the T-cell receptor (TCR) repertoire, has long been considered infeasible because patient-derived TCRs appear to lack convergent sequence motifs. We reasoned that this apparent absence of shared TCR features likely reflects both insufficient sample sizes and unaccounted immune heterogeneity within the iPD population.
We reconstructed TCR repertoires from the two largest iPD cohorts currently available, anchoring them with three mechanistically distinct mouse models to stratify patients into model-anchored informed subtypes. Within these data-driven subtypes, we trained subtype-specific, multimodal multi-instance classifiers.
We demonstrated that iPD patients can be successfully stratified into model-anchored informed subtypes. Furthermore, the trained subtype-specific, multimodal multi-instance classifiers achieved an Area Under Curve (AUC) exceeding 0.8 for both subtypes.
Our findings underscore the critical role of disease stratification in enabling TCR repertoire-based modeling in neurodegenerative diseases.

PMID:
42907884
Bibliographic data and abstract were imported from PubMed on 23 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement